Bluejay Diagnostics, Inc.
BJDX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001704287
In the last 90 days, Bluejay Diagnostics, Inc. insiders filed 1 open-market purchase and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $259.3K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Bluejay Diagnostics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −1 vs. Q4 2021
- Shares held
- 87.5K
- −16.8K (−16.1%) vs. Q4 2021
- Total value
- $98.0K
- −$169.0K (−63.3%) vs. Q4 2021
- New holders
- 1
- 4 more added
- Sold out
- 2
- 1 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BJDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $259.3K |
| Q1 2026 | 6 | $108.2K |
| Q4 2025 | 9 | $112.3K |
| Q3 2025 | 4 | $142.7K |
| Q2 2025 | 5 | $170.3K |
| Q1 2025 | 4 | $9.61K |
| Q4 2024 | 3 | $12.2K |
| Q3 2024 | 13 | $129.0K |
| Q2 2024 | 5 | $118.6K |
| Q1 2024 | 9 | $344.7K |
| Q4 2023 | 7 | $243.4K |
| Q3 2023 | 6 | $99.8K |
| Q2 2023 | 11 | $47.4K |
| Q1 2023 | 10 | $55.7K |
| Q4 2022 | 14 | $109.0K |
| Q3 2022 | 12 | $146.0K |
| Q2 2022 | 12 | $258.0K |
| Q1 2022 | 8 | $98.0K |
| Q4 2021 | 9 | $267.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Bluejay Diagnostics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 58 | $0 | 0.00% | +45+346.2% | Added |
| Advisor Group Holdings, Inc. | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,591 | $6.00K | 0.00% | +577+11.5% | Added |
| Tower Research Capital LLC (TRC) | 7,119 | $8.00K | 0.00% | +6,892+3,036.1% | Added |
| Verition Fund Management LLC | 15,000 | $17.0K | 0.00% | +15,000 | New |
| Jane Street Group, LLC | 15,913 | $18.0K | 0.00% | −7,835−33.0% | Reduced |
| BlackRock Inc. | 20,835 | $23.0K | 0.00% | +16,489+379.4% | Added |
| Perkins Capital Management Inc | 22,500 | $25.0K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 0 | $0 | 0.00% | −32,170−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,806−100.0% | Sold out |